电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD33 (Gemtuzumab Biosimilar) 抗体

This anti-CD33 (Gemtuzumab Biosimilar) antibody is a Humanized 单克隆 antibody detecting CD33 (Gemtuzumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795111
发货至: 中国

Quick Overview for Recombinant CD33 (Gemtuzumab Biosimilar) 抗体 (ABIN7795111)

抗原

CD33 (Gemtuzumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 3
  • 1
  • 1
  • 1
  • 1
Humanized

克隆类型

  • 4
  • 3
单克隆

标记

  • 6
  • 1
This CD33 (Gemtuzumab Biosimilar) antibody is un-conjugated

应用范围

  • 5
  • 3
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Gemtuzumab Biosimilar, CD33 Monoclonal Antibody

    产品特性

    Gemtuzumab is a recombinant humanized IgG4 kappa antibody which is conjugated with calicheamicin derivative, a cytotoxic antitumor antibiotic isolated from fermentation of Micromonospora echinospora ssp. calichensis. Gemtuzumab ozogamicin has approximately 50 % of the antibody loaded with 4-6 Moles calicheamicin per mole of antibody Label. The antibody is specifically directed against the CD33 antigen present on leukemic myeloblasts in most patients with acute myeloid leukemia (AML). By binding to the CD33 antigen on tumors, the cytotoxic agent blocks the growth of cancerous cells and causes cell death. Gemtuzumab is directed against the CD33 antigen expressed by hematopoietic cells. Binding of the anti-CD33 antibody portion of Gemtuzumab with the CD33 antigen results in the formation of a complex that is internalized. Upon internalization, the calicheamicin derivative is released inside the lysosomes of the myeloid cell. The released calicheamicin derivative binds to DNA in the minor groove resulting in site-specific DNA double strand breaks via formation of a p-benzene diradical. Eventually, cell death is induced.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    免疫原

    Human CD33
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    CD33 (Gemtuzumab Biosimilar)

    别名

    Gemtuzumab Biosimilar

    物质类

    Biosimilar
You are here:
Chat with us!